2020
DOI: 10.2967/jnumed.119.239418
|View full text |Cite
|
Sign up to set email alerts
|

Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders

Abstract: Our rationale was to conduct a retrospective study comparing 3 123 I-N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane ( 123 I-FP-CIT) SPECT quantitative methods in patients with neurodegenerative syndromes as referenced to neuropathologic findings. Methods: 123 I-FP-CIT-SPECT and neuropathologic findings among patients with neurodegenerative syndromes from the Mayo Alzheimer Disease Research Center and Mayo Clinic Study of Aging were examined. Three 123 I-FP-CIT SPECT quantitative assessment method… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
18
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 46 publications
(34 reference statements)
2
18
0
1
Order By: Relevance
“…Elevated amyloid-β burden on Pittsburgh compound-B (PiB) PET 6 , was reported in more than half of patients with DLB 7 and has been associated with greater cognitive impairment in DLB 8 . The quantitative analysis of antemortem 123 I-FP-CIT SPECT demonstrated excellent discrimination between patients with and without autopsy-confirmed LB disease, supporting the utility of 123 I-FP-CIT SPECT as a biomarker for the underlying Lewy-related pathology in MCI-LB 12 .…”
Section: Introductionmentioning
confidence: 72%
See 4 more Smart Citations
“…Elevated amyloid-β burden on Pittsburgh compound-B (PiB) PET 6 , was reported in more than half of patients with DLB 7 and has been associated with greater cognitive impairment in DLB 8 . The quantitative analysis of antemortem 123 I-FP-CIT SPECT demonstrated excellent discrimination between patients with and without autopsy-confirmed LB disease, supporting the utility of 123 I-FP-CIT SPECT as a biomarker for the underlying Lewy-related pathology in MCI-LB 12 .…”
Section: Introductionmentioning
confidence: 72%
“…A 123 I-FP-CIT SPECT (DaTscan, GE Healthcare, Chicago, IL) was performed according to previously published protocol for each participant. 12 In brief, at least 1 hour before the injection of 123 I-ioflupane, a 100 mg Lugol solution was given, and then the recommended 123 I-ioflupane dose of 111 to 185 MBq (3–5 mCi) was slowly administered intravenously. SPECT imaging occurred 3 to 6 hours after injection.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations